National Institute Forpharmaceutical Technology And Educa
- Assets
- $1.1m
- Revenue
- $998.0k
- Investments
- $0.0
- Employees
- 0
- Location
- Minneapolis, MN
- Founding
- 01/2008
- Data as of
- 06/2022
- EIN
- 26-0636598
Organization Overview
National Institute Forpharmaceutical Technology And Educa, operating under the name Nipte, is located in Minneapolis, MN. The organization was established in 2008. According to its NTEE Classification (T12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Nipte is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Nipte generated $998.0k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 4 years, the organization has seen revenues fall by an average of (25.3%) each year. All expenses for the organization totaled $1.2m during the year ending 06/2022. As we would expect to see with falling revenues, expenses have declined by (22.7%) per year over the past 4 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, Nipte has awarded 29 individual grants totaling $4,497,858. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCATION (NIPTE) IS A COLLABORATION OF ACADEMIA, INDUSTRY AND OTHER STAKEHOLDERS USING RESEARCH, OUTREACH AND EDUCATION TO SUPPORT THE MISSION. NIPTE LEVERAGES SCIENTIFIC AND TECHNOLOGICAL ADVANCES TO BRING CONFIDENCE AND RELIABILITY FOR PHARMACEUTICAL PRODUCTS TO CONSUMERS WORLDWIDE. NIPTE'S MISSION IS TO IMPROVE THE WAY MEDICINES ARE DESIGNED, DEVELOPED AND MANUFACTURED TO MEET THE NEEDS OF PATIENTS IN THE 21ST CENTURY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THESE PROJECTS SUPPORT NIPTE'S MISSION TO MAKE MEDICINES MORE AFFORDABLE AND OF HIGHER QUALITY. IN ADDITION, NIPTE SUPPORTED THE EDUCATION COMPONENT BY DEVELOPING AND DELIVERING ADVANCED PHARMACEUTICAL TOPICS TO THE WORKFORCE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Natalie D Eddington Board Member | Trustee | 1 | $0 |
Indra K Reddy Chair | OfficerTrustee | 1 | $0 |
Kenneth Christensen Board Member | Trustee | 1 | $0 |
Bruce A Mueller Board Member | Trustee | 1 | $0 |
Lynda S Welage Secretary | OfficerTrustee | 1 | $0 |
Eric L Barker Board Member | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $270,000 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $210,895 |
| All other contributions, gifts, grants, and similar amounts not included above | $340,014 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $820,909 |
| Total Program Service Revenue | $159,086 |
| Investment income | $18,014 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $998,016 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $861,386 |
| Grants and other assistance to domestic individuals. | $58,324 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $206,582 |
| Fees for services: Legal | $1,343 |
| Fees for services: Accounting | $4,000 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $899 |
| Advertising and promotion | $3,051 |
| Office expenses | $511 |
| Information technology | $3,464 |
| Royalties | $0 |
| Occupancy | $2,347 |
| Travel | $2,219 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $500 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,893 |
| All other expenses | $358 |
| Total functional expenses | $1,150,877 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $48,165 |
| Savings and temporary cash investments | $683,130 |
| Pledges and grants receivable | $292,277 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $6,644 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $37,780 |
| Total assets | $1,067,996 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $240,192 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $4,780 |
| Total liabilities | $244,972 |
| Net assets without donor restrictions | $823,024 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,067,996 |
Grants Awarded
Over the last fiscal year, National Institute Forpharmaceutical Technology And Educa has awarded $860,883 in support to 9 organizations.
| Grant Recipient | Amount |
|---|---|
PURDUE UNIVERSITY PURPOSE: FDA subgrant awards for pharmaceutical research | $111,434 |
RUTGERS UNIVERSITY PURPOSE: FDA subgrant awards for pharmaceutical research | $17,505 |
UNIVERSITY OF MINNESOTA PURPOSE: FDA subgrant awards for pharmaceutical research | $34,800 |
UNIVERSITY OF CONNECTICUT PURPOSE: FDA subgrant awards for pharmaceutical research | $92,303 |
UNIVERSITY OF MARYLAND PURPOSE: FDA subgrant awards for pharmaceutical research | $210,517 |
TEXAS A AND M UNIVERSITY PURPOSE: FDA subgrant awards for pharmaceutical research | $112,195 |